AMYLOIDOSIS
Clinical trials for AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to halt rare protein disease in its tracks
Disease control Not yet recruitingThis study tests a new drug combination for adults recently diagnosed with AL amyloidosis, a rare disease where abnormal proteins build up in organs. About 60 participants will receive belantamab mafodotin plus standard chemotherapy to see if it improves blood and organ health. T…
Matched conditions: AMYLOIDOSIS
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Heart rehab trial aims to boost life quality for amyloidosis patients
Symptom relief Not yet recruitingThis study tests whether a 5-week cardiac rehabilitation program can improve exercise ability and quality of life in adults with cardiac amyloidosis. Researchers will measure heart and lung function, symptoms, and well-being before and after the program. The goal is to see if thi…
Matched conditions: AMYLOIDOSIS
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated May 17, 2026 04:17 UTC